Contrast-enhanced three-dimensional angiography

Rapid advances in the techniques of contrast-enhanced MR angiography (MRA) have made it possible to evaluate the entire aorta and main arteries as well as small arteries and veins of the whole body. In this article, the technical aspects and clinical applications of contrast-enhanced MRA are reviewed. Dynamic contrast-enhanced three-dimensional (3D) MRA is a first-pass vascular imaging technique that uses the 3D fast field echo sequence with rapid bolus injection of contrast material. By repeating imaging sequences, it is possible to trace the dynamics of the injected contrast material over time and apply various postprocessing techniques, such as double subtraction and addition, to demonstrate arteries and veins separately and to display the arteries in a single image, even when circulation time is prolonged. This technique is flexible enough to be applied in a variety of clinical settings by optimizing the examination. The abdominal aorta and main arteries of the lower extremities are examined by two methods, dynamic subtraction 3D MRA (MRDSA) and the moving-bed method. Three bolus injections of contrast material are used in MRDSA. In contrast, a slow continuous injection of a large dose (20 ml or more) of contrast material is used in the moving-bed method, which is a convenient, useful method of contrast-enhanced MR angiography when the study must focus on arterial imaging. Clinical indications include atherosclerotic occlusive disease, Takayasu arteritis, aortic dissection, anti-phospholipid antibody syndrome, aneurysm, patent and occluded bypass graft, and deep vein thrombosis, among others. The problem with contrast-enhanced MRA is its difficulty in depicting small vessels such as mesenteric arteries, distal renal arteries, and peripheral small arteries. The nature of gradient-echo sequences has certain inherent problems for the imaging of small vessels. The fat-tissue interface becomes dark because of chemical shift artifact (which occurs both when the echo time is set in-phase and when it is set out-of-phase), reducing the ability to detect small arteries with contrast-enhanced MR angiography. The fat suppression technique is very useful for satisfactorily demonstrating small vessels by reducing chemical shift artifact. MR angiography remains an exciting and challenging field, and the best methods of contrast-enhanced MR angiography will be developed and established on the foundation of all previous work.     

Three-dimensional contrast-enhanced magnetic resonance angiography of the thoracic vasculature

Magnetic resonance angiography (MRA) has become a useful non-invasive imaging technique for the assessment of vascular disease. Due to limitations such as respiratory motion artefacts, saturations problems, and long acquisition times, applications of MRA in the thorax have largely been restricted to imaging of the aorta. The recent introduction of breath-hold three-dimensional (3D) contrast-enhanced MRA promises not only to enhance conventional MR protocols for aortic imaging, but to extend the clinical indications of MRI to diseases affecting other vascular structures of the thorax, most notably the pulmonary arteries. This article describes the technical aspects of contrast-enhanced 3D MRA and reviews existing and potential future clinical applications. Received 17 September 1996; Revision received 6 November 1996; Accepted 8 November 1996     

MR Diagnosis of a Pulmonary Embolism: Comparison of P792 and Gd-DOTA for First-Pass Perfusion MRI and Contrast-Enhanced 3D MRA in a Rabbit Model

Objective

To compare P792 (gadomelitol, a rapid clearance blood pool MR contrast agent) with gadolinium-tetraazacyclododecanetetraacetic acid (Gd-DOTA), a standard extracellular agent, for their suitability to diagnose a pulmonary embolism (PE) during a first-pass perfusion MRI and 3D contrast-enhanced (CE) MR angiography (MRA).

Materials and Methods

A perfusion MRI or CE-MRA was performed in a rabbit PE model following the intravenous injection of a single dose of contrast agent. The time course of the pulmonary vascular and parenchymal enhancement was assessed by measuring the signal in the aorta, pulmonary artery, and lung parenchyma as a function of time to determine whether there is a significant difference between the techniques. CE-MRA studies were evaluated by their ability to depict the pulmonary vasculature and following defects between 3 seconds and 15 minutes after a triple dose intravenous injection of the contrast agents.

Results

The P792 and Gd-DOTA were equivalent in their ability to demonstrate PE as perfusion defects on first pass imaging. The signal from P792 was significantly higher in vasculature than that from Gd-DOTA between the first and the tenth minutes after injection. The results suggest that a CE-MRA PE could be reliably diagnosed up to 15 minutes after injection.

Conclusion

P792 is superior to Gd-DOTA for the MR diagnosis of PE.     

MR angiography of the lower extremities

OBJECTIVE: Current MRI technology and postprocessing tools have enabled 3D contrast-enhanced MR angiography (MRA) to evolve into a first-line noninvasive diagnostic tool to evaluate vascular disorders. CONCLUSION: In this article, 3D MRA techniques, bolus timing issues, new IV contrast agents allowing a steady-state acquisition, principals of postprocessing, and unenhanced MRA techniques are reviewed and how to effectively use 3D gadolinium-enhanced MRA for peripheral arterial imaging is described.     

Real-time MR with TrueFISP for the detection of acute pulmonary embolism: initial clinical experience

The feasibility and diagnostic value of real-time magnetic resonance imaging (RT-MRI) for the diagnosis of acute pulmonary embolism (PE) was evaluated by comparing RT-MRI and magnetic resonance angiography (MRA). In 39 consecutive patients with suspected PE real-time true fast imaging with steady-state precession (TrueFisp) was prospectively compared with contrast-enhanced MRA on a 1.5-T MR scanner. The TrueFisp sequence used allowed acquisition of T2-weighted images at 0.4 s per image so that the pulmonary vasculature could be visualized in three orientations in <3 min without the need for breath holding or contrast media application. Results of additional scintigraphic pulmonary perfusion examinations were available from 17 patients. All 39 primary RT examinations (100%) and 30 of 39 MRA examinations (77%) were of diagnostic quality. The reasons underlying failure to achieve diagnostic quality for MRA were breathing artifacts among dyspneic patients in all 9 cases. Compared with MRA, the sensitivities and specificities of RT sequences for PE were 93 and 100% (per examination), 96 and 100% (lobar artery PE), and 97 and 100% (segmental artery PE), respectively. Compared with scintigraphy, the sensitivity and specificity of RT-MRI were 83 and 100%, respectively. The MRA reached 100% sensitivity and specificity in this subgroup. The RT-MRI proved to be very robust and undisturbed by respiratory movements and patient cooperation. Its image quality assured fast diagnostic examinations, and its sensitivity and specificity, compared with MRA and scintigraphy, were sufficient to allow the diagnosis of acute central, lobar, and segmental PE; therefore, the emergency diagnosis of PE using RT-MRI is feasible and reliable.     

Pulmonary hemorrhage: Imaging with a new magnetic resonance blood pool agent in conjunction with breathheld three-dimensional magnetic resonance angiography

Purpose: To describe the three-dimensional magnetic resonance angiography (3D MRA) imaging appearance of the pulmonary arteries following administration of a superparamagnetic iron oxide blood pool agent to human volunteers, and to demonstrate in an animal model (pigs) how this technique can be used to detect pulmonary parenchymal hemorrhage. Methods: Two volunteers were examined following the intravenous administration of a superparamagnetic iron oxide blood pool agent (NC100150 Injection, Nycomed Amersham Imaging, Wayne, PA, USA). T1-weighted 3D gradient recalled echo (GRE) image sets (TR/TE 5.1/1.4 msec, flip angle 30°) were acquired breathheld over 24 sec. To assess the detectability of pulmonary bleeding with intravascular MR contrast, pulmonary parenchymal injuries were created in two animals under general anesthesia, and fast T1-weighted 3D GRE image sets collected before and after the injury. Results: Administration of the intravascular contrast in the two volunteers resulted in selective enhancement of the pulmonary vasculature permitting complete visualization and excellent delineation of central, segmental, and subsegmental arteries. Following iatrogenic injury in the two animals, pulmonary hemorrhage was readily detected on the 3D image sets. Conclusion: The data presented illustrate that ultrafast 3D GRE MR imaging in conjunction with an intravenously administered intravascular blood pool agent can be used to perform high-quality pulmonary MRA as well as to detect pulmonary hemorrhage.     

Magnetic resonance imaging in the assessment of urologic disease: an all-in-one approach

The aim of this study was to evaluate an “all-in-one” MR procedure to examine the kidneys, the renal vascular supply and renal perfusion, and the urinary tract. In 64 patients (58 with urologic disease and 6 healthy volunteers), MR was performed including: (a) T1- and T2-weighted imaging; (b) 3D contrast-enhanced MR angiography (MRA), including the renal arteries, renal veins, as well as renal perfusion; and (c) 3D contrast-enhanced MR urography (MRU) in the coronal and sagittal plane. For the latter, low- and high-resolution images were compared. Prior to gadolinium injection, 0.1 mg/kg body weight of furosemide was administered intravenously. The results were compared with correlative imaging modalities (ultrasonography, intravenous urography, CT), ureterorenoscopy and/or surgical–pathologic findings. Visualization of the renal parenchyma, the vascular supply, and the collecting system was adequate in all cases, both in nondilated and in dilated systems and irrespective of the renal function. One infiltrating urothelial cancer was missed; there was one false-positive urothelial malignancy. Different MR techniques can be combined to establish an all-in-one imaging modality in the assessment of diseases which affect the kidneys and urinary tracts. Continuous refinement of the applied MR techniques and further improvements in spatial resolution is needed to expand the actual imaging possibilities and to create new tracts and challenges in the MR evaluation of urologic disease. Received: 27 September 1999; Revised: 20 January 2000; Accepted: 22 May 2000     

MR Angiography of the iliofemoral artery system

Summary During the last years, magnetic resonance angiography (MRA) has become a widely used modality for intracerebral and carotid artery imaging. Due to technical limitations, the clinical impact of MRA in the iliofemoral arteries has been rather poor. New developments in MRA like ECG-triggered sequences and the occurrence of contrast-enhanced MRA has overcome most of these limitations. Therefore, a major advance in clinical use of these diagnostic tools can be predicted. This paper discussed the advantages of ECG-gated 2D-Phase contrast, ECG-gated 2D-Time-of-Flight and contrast enhanced FLASH 3D angiography sequences from a clinical point of view. 2D-PC-MRA is a robust technique, which provides an overview of the iliofemoral artery system in less than 5 minutes. Limitations are the true 2D impression of the sequence and the partial venous overlay. 2D-TOF-MRA on the other hand is time consuming, however it enables 3D reconstruction and effective venous suppression can be applied. Contrast enhanced MRA as the third sequence discussed provides high resolution images in less than 30 sec. However contrast bolus timing might be a problem. In conclusion the authors suggest a combination of 2D-PC-MRA and additional 2D-TOF sequences at questionable vacular areas as the modality of choice, due to the fact, that MRA of the iliofemoral arteries ist mostly only one step of a complete lower limb examination. Contrast MRA might become the method of choice in the future however problems with multiple contrast injections and upper limits of contrast dose have to be solved.      

Magnetic resonance angiography of the peripheral arteries: current status

Comprehensive imaging of the peripheral vasculature has traditionally only been possible with catheter angiography. With the introduction of time-of-flight magnetic resonance angiography (TOF MRA), non-invasive imaging of the peripheral arteries became a clinical reality; however, widespread adoption of TOF MRA did not occur due to long scan times and artefacts which precluded its use as a screening tool. Contrast-enhanced MRA, an extremely time-efficient technique with minimal associated artefacts, addresses most of the limitations of non-contrast techniques. Numerous technological advances, including bolus detection, optimized 3D volume placement, improved k-space filling mechanisms and the evolution from single-station to multi-location moving-table contrast-enhanced MRA, have facilitated the development of non-invasive evaluation of the peripheral vascular tree with contrast-enhanced techniques. Electronic Publication     

Pulmonary MR angiography and perfusion imaging—A review of methods and applications

The pulmonary vasculature and its role in perfusion and gas exchange is an important consideration in many conditions of the lung and heart. Currently the mainstay of imaging of the vasculature and perfusion of the lungs lies with CT and nuclear medicine perfusion scans, both of which require ionizing radiation exposure. Improvements in MRI techniques have increased the use of MRI in pulmonary vascular imaging. Here we review MRI methods for imaging the pulmonary vasculature and pulmonary perfusion, both using contrast enhanced and non-contrast enhanced methodology.In many centres pulmonary MR angiography and dynamic contrast enhanced perfusion MRI are now well established in the routine workflow of patients particularly with pulmonary hypertension and thromboembolic disease. However, these imaging modalities offer exciting new directions for future research and clinical use in other respiratory diseases where consideration of pulmonary perfusion and gas exchange can provide insight in to pathophysiology.     

MR angiography of the renal arteries

During, the past decade. MRA has evolved from an cxperimental technique into the modality of choice for the noninvasive evaluation of renovascular disease. The recent widespread application of MRA for these indications has been driven primarily by the advent of 3D contrast-enhanced MRA. which provides a fast, reliable technique for imaging large vascular territories and generates images, after postprocessing, similar in appearance to digital subtraction angiography. The cross-sectional volumetric nature of contrast-enhanced MRA affords some advantages over conventional catheter angiography. Although 3D contrast-enhanced MRA forms the backbone of vascular MR studies, several adjunctive sequences are employed to maximize the diagnostic yield of the examination. For example. flow-dependant imaging is used to complement the morphologic images of contrast-enhanced MRA by providing hemodynamic information. As such, MRA is unique among noninvasive imaging modalities in that it offers a comprehensive evaluation of anatomy and function. The availability and reliability of MRA extend renal artery screening to a wider spectrum of patients. Current applications of renal MRA range from detection of renal artery stenosis to evaluation for renal transplant donors.     

Gadomer-17-enhanced 3D navigator-echo MR angiography of the pulmonary arteries in pigs

The goal of this study was visualisation and quality assessment of the pulmonary arteries in pigs with modified navigator-echo magnetic resonance angiography using an intravascular contrast agent. Five sedated pigs were examined in a clinical 1.5-T system with modified three-dimensional navigator-echo magnetic resonance angiography (slice thickness 3 mm, pixel size 2.4x1.8 mm2) to evaluate the pulmonary arteries. Using a phased-array four-element thorax coil the entire thorax was scanned before and after intravenous infusion of a gadolinium-based intravascular contrast agent. Assessment of image quality, enhancement-related contrast-to-noise ratio (CNR) measurements and improvement of visibility of peripheral pulmonary vessels was performed. Improvement of quality using Gadomer-17 was found for smaller vessels; pulmonary trunks and the main pulmonary arteries were sufficiently imaged without enhancement. Mean rise of CNR measured in the pulmonary trunks was 28.64% ( P=0.0002), mean rise of CNR in the main pulmonary arteries and the segmental arteries were 79.6% and 148.2%, respectively. Mean distance between the visible peripheral end of 60 sub-segmental arteries and the inner thoracic wall was 12.2 +/- 0.4 mm, and was significantly ( P=0.00002) reduced after contrast infusion to 8.0 +/- 0.4 mm. The combination of inherent flow sensitivity of navigator-echo angiography and Gadomer-17 proved effective for imaging of the pulmonary arteries. In contrast to standard contrast-enhanced pulmonary MRA studies, breath holding is not required. Further studies and the evaluation of findings of patients suffering from pulmonary embolism are needed to evaluate the possible benefits of a higher spatial resolution which is achievable using navigator-echo techniques in contrast to the higher temporal resolution of ultra-fast pulmonary MRA.     

MR angiography of the carotid arteries and intracranial circulation: advantage of a high relaxivity contrast agent

Several studies have shown the usefulness of contrast-enhanced MR angiography (CE-MRA) for imaging the supraortic vessels, and, as a consequence, it has rapidly become a routine imaging modality. The main advantage over unenhanced techniques is the possibility to acquire larger volumes, allowing demonstration of the carotid artery from its origin to the intracranial portion. Most published studies on CE-MRA of the carotid arteries have been performed with standard Gd-based chelates whose T1 relaxivity values are similar. Recently new gadolinium chelates such as gadobenate dimeglumine (Gd-BOP-TA, MultiHance; Bracco Imaging, Milan, Italy) have been developed which have markedly higher intravascular T1 relaxivity values. When administered at an equivalent dose to that of a standard agent, these newer contrast agents produce significantly greater intravascular signal enhancement. The availability of an appropriate high-relaxivity contrast agent might also help to overcome some of the intrinsic technical problems (e. g. those related to flow) that affect time-of-flight (TOF) and phase contrast (PC) MR angiography of the intracranial vasculature. To avoid the problem of superimposition of veins, ultrafast gradient echo MRA techniques with very short TR and TE have been developed. Although the precise sequence parameters vary between manufacturers, they are basically similar. The choice between performing a time-resolved or high spatial resolution CE-MRA examination depends upon the precise clinical application. The most common applications include the study of cerebral aneurysms, arteriovenous malformations, dural arteriovenous fistulas and dural venous diseases.     

Contrast-enhanced 3D FISP MR angiography of the aortic arch ostia: preliminary results

PURPOSE: The goal of this work was to evaluate three-dimensional (3D) contrast-enhanced MR angiography (MRA) for the detection of ostial stenoses of the aortic arch. METHOD: Sixteen patients with suspected carotid atherosclerotic disease prospectively underwent digital subtraction angiography of the aortic arch followed by contrast-enhanced MRA using a 3D fast imaging with steady-state precession (FISP) technique (TR = 5 ms, TE = 2 ms, flip angle = 30 degrees). Three neuroradiologists blindly measured stenoses on the catheter angiograms and MRA. Evaluation included the ostia of the innominate, left carotid, and left subclavian arteries. Any significant disagreement on catheter angiography was resolved by consensus. The MRA grades of each of the three observers were then compared with the consensus grades of the contrast angiogram. RESULTS: Forty-eight vessels were scored, of which five had significant stenoses. MRA demonstrated 100% sensitivity, 89% specificity, 52% positive predictive value, and 100% negative predictive value. The Bowker test for symmetry indicated no significant difference between conventional angiography and MRA scores (p = 0.32-0.75), and there was good agreement between the three observers (weighted kappa = 0.75-0.86). CONCLUSION: Contrast-enhanced 3D FISP MRA may be a useful imaging modality for the detection of significant stenoses at the ostia of the major aortic arch branches.     

Pulmonary magnetic resonance angiography.

Early attempts to image the pulmonary vasculature with spin-echo magnetic resonance (MR) imaging were hampered by severe image degradation related to respiratory and cardiac pulsation artifact, susceptibility at interfaces between lung parenchyma and vessel wall, and poor contrast between flowing blood and intravascular filling defects of emboli. With the development of gradient-echo MR angiographic techniques some of these limitations were overcome; however, the need for multiple breath-holds and the frequent occurrence of flow-related artifacts that could simulate pulmonary emboli diminished their clinical utility. With the development of contrast-enhanced MR angiography, many of the limitations of earlier techniques were addressed. Images of both lungs with high signal-to-noise ratios and high contrast between flowing blood and pulmonary emboli could be acquired in a single breath-hold, during "first-pass" imaging with extracellular contrast agents in the coronal plane. However, subsegmental vessels could not be assessed with this approach. The technique has been refined further by imaging each lung separately in the sagittal plane; this offers higher resolution and total lung coverage and requires a shorter breath-hold. Finally, several investigators have reported preliminary data on imaging of the pulmonary vasculature with blood pool agents, exploiting respiratory triggering or navigator echoes to eliminate the need for breath-holding for the detection of pulmonary emboli.     

Gadofosveset-enhanced MR angiography of the pedal arteries in patients with diabetes mellitus and comparison with selective intraarterial DSA

To compare gadofosveset-enhanced magnetic resonance angiography (MRA) of the pedal vasculature with selective intraarterial DSA. Eighteen patients with PAOD and type II diabetes were prospectively examined at 1.5 T. For contrast enhancement, 0.03 mmol/kg body weight gadofosveset was used. MR imaging consisted of dynamic and of high-resolution steady-state imaging. Selective digital subtraction angiography (DSA) was performed within 5 days and served as standard of reference. Image analysis was done by two observers. There were no differences between MRA and DSA regarding overall image quality. First-pass MRA detected significantly more patent vessel segments than did DSA (P < 0.001, kappa = 0.46). Interobserver agreement of MRA was very good with respect to the detection of patent vessel segments and the assessment of hemodynamically relevant stenoses (kappa = 0.97 and 0.89, respectively). Steady-state imaging depicted significantly more patent metatarsal arteries than did dynamic imaging, and delineated inflammatory complications including osteomyelitis, soft-tissue abscesses, and fistulas related to the diabetic foot. Gadofosveset-enhanced MRA of the pedal vasculature proved to be superior to DSA. It offered a long imaging time window, and allowed for better depiction of the pedal outflow. Steady-state imaging delineated inflammatory complications associated with the diabetic foot.     

肾动脉高分辨力三维增强磁共振血管成像术:透视触发和并行采集技术使用初探

目的:评估透视触发和并行采集技术用于肾动脉高分辨力三维增强磁共振血管成像术的可行性和对肾动脉的显影诊断效果。方法:90例临床诊断或怀疑肾动脉或腹主动脉病变的患者行高分辨力肾动脉三维增强磁共振血管成像(3D CE MRA)。使用透视触发软件启动肾动脉3D CE MRA扫描,扫描采用K空间中心填充法和加速因子为2的并行采集技术。分析图象质量和病变显示情况,并与其它检查结果对照。结果:肾动脉3D CE MRA显示了90例患者共810支动脉段(100%显示率),平均显示等级为3.88。3D CE MRA显示8例11支副肾动脉,显示等级均为4.0。肾动脉段级分支的显示率为73%(66/90例)。所有病例在动脉显示区静脉均未显影或显影很淡,平均等级为0.20。3D CE MRA发现639支动脉段正常;66支动脉段管壁不规则;55支动脉段轻度狭窄;37支动脉段严重狭窄;2支动脉段闭塞;11支动脉段动脉瘤形成。其中96支肾动脉存在狭窄,11支副肾动脉均正常。共有43例病例,肾动脉3D CE MRA与其它血管成像技术作了比较,3D CE MRA的检查结果与之完全符合。结论:透视触发并行采集肾动脉高分辨力3D CE MRA简单可行,成像时间短,空间分辨力高,能清楚显示肾动脉且无静脉污染。     

3D pulmonary perfusion MRI and MR angiography of pulmonary embolism in pigs after a single injection of a blood pool MR contrast agent

The purpose of this study was to assess the feasibility of contrast-enhanced 3D perfusion MRI and MR angiography (MRA) of pulmonary embolism (PE) in pigs using a single injection of the blood pool contrast Gadomer. PE was induced in five domestic pigs by injection of autologous blood thrombi. Contrast-enhanced first-pass 3D perfusion MRI (TE/TR/FA: 1.0 ms/2.2 ms/40°; voxel size: 1.3×2.5×4.0 mm³; TA: 1.8 s per data set) and high-resolution 3D MRA (TE/TR/FA: 1.4 ms/3.4 ms/40°; voxel size: 0.8×1.0×1.6 mm³) was performed during and after a single injection of 0.1 mmol/kg body weight of Gadomer. Image data were compared to pre-embolism Gd-DTPA-enhanced MRI and post-embolism thin-section multislice CT (n=2). SNR measurements were performed in the pulmonary arteries and lung. One animal died after induction of PE. In all other animals, perfusion MRI and MRA could be acquired after a single injection of Gadomer. At perfusion MRI, PE could be detected by typical wedge-shaped perfusion defects. While the visualization of central PE at MRA correlated well with the CT, peripheral PE were only visualized by CT. Gadomer achieved a higher peak SNR of the lungs compared to Gd-DTPA (21±8 vs. 13±3). Contrast-enhanced 3D perfusion MRI and MRA of PE can be combined using a single injection of the blood pool contrast agent Gadomer.     

Value of image subtraction in 3D gadolinium-enhanced MR angiography of the renal arteries

The objective of this study was to evaluate quantitatively and qualitatively the effect of image subtraction on the image quality of three-dimensional (3D) gadolinium-enhanced MR angiograms of the renal arteries. Breath-hold 3D gadolinium MR angiography (MRA) as well as conventional contrast angiography of the renal arteries was performed on 20 patients with suspected renovascular hypertension. MR angiograms were acquired before and during dynamic infusion of gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA). Contrast-enhanced images were compared with images that had undergone voxel-by-voxel signal intensity subtraction of contrast-enhanced data from precontrast data. One false positive finding for significant renal artery stenosis was recorded with MRA using conventional angiography as the gold standard. Image subtraction did not alter the diagnosis at MRA in any case. The mean contrast-to-noise ratio (CNR) was significantly higher (P < .05) on the subtraction MR angiograms compared to the nonsubtracted MR angiograms. There was no significant difference in the signal-to-noise ratio (SNR). Qualitative analysis revealed a significant improvement in image quality after image subtraction with respect to visualization of the distal renal arteries. In conclusion, image subtraction improves the quality of renal MRA in terms of both CNR and visualization of the distal renal arteries.     

Pulmonary circulation

Evaluation of the pulmonary vasculature is mainly indicated in patients with suspected pulmonary thromboembolism. The routine procedure so far is ventilation-perfusion scintigraphy alone or in combination with diagnostic assessment of the legs to rule out deep venous thrombosis. The results are still not reliable for the majority of patients. In the case of equivocal diagnosis, invasive conventional angiography is considered the gold standard. With steady improvements in tomographic imaging techniques, such as computed tomography (CT) or magnetic resonance imaging (MRI), non-invasive alternatives to the routine diagnostic work-up are given. Helical CT and CTA techniques are already in clinical use and estimated to sufficiently serve the demands for detection/exclusion of pulmonary thromboembolism. The disadvantages mainly concern peripheral disease and reconstruction artifacts. MRI and MR angiography have been implemented in the diagnosis of pulmonary vascular disease since the introduction of contrast-enhanced MRA. In breath-hold techniques, the entire lung vascularization can be delineated and thromboemboli can be detected. The clinical experience in this field is limited, but MRI has the potential to demonstrate its superiority over CT due to its improved delineation of the vascular periphery and the more comprehensive three-dimensional reconstruction. Received: 20 January 1998; Accepted: 10 February 1998